Selective serotonin reuptake inhibitors pathway
- 1 November 2009
- journal article
- pharmgkb summary
- Published by Ovid Technologies (Wolters Kluwer Health) in Pharmacogenetics and Genomics
- Vol. 19 (11), 907-909
- https://doi.org/10.1097/fpc.0b013e32833132cb
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Long‐term treatment with fluoxetine induces desensitization of 5‐HT4 receptor‐dependent signalling and functionality in rat brainJournal of Neurochemistry, 2009
- Emerging role of glutamate in the pathophysiology of major depressive disorderBrain Research Reviews, 2009
- Molecular biology of 5-HT receptorsBehavioural Brain Research, 2008
- Review: Bupropion and SSRI-induced side effectsJournal of Psychopharmacology, 2008
- Serotonin type 3 receptor genes: HTR3A, B, C, D, EPharmacogenomics, 2008
- Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatmentsBrain Research, 2008
- Pharmacogenetics of antidepressant response: An updateHuman Genomics, 2008
- Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brainBiochemical Pharmacology, 2007
- Physiology and Pathophysiology of the Serotonergic System and its Implications on Mental and Physical Performance. Part IInternational Journal of Sports Medicine, 2001
- Pharmacokinetics of selective serotonin reuptake inhibitorsPharmacology & Therapeutics, 1999